Trial intelligence / Profile preview

Calcitriol in IgA Nephropathy

NCT00319761Phase 4Completed

Sponsor
The Chinese University of Hong Kong
Start
May 2006
Primary completion
Sep 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of calcitriol in IgA nephropathy (IgAN), sponsored by The Chinese University of Hong Kong. Primary endpoint: Change in the degree of proteinuria at 12 weeks. Started May 2006; status: completed.

02

Drugs

calcitriol
03

Conditions

IgA nephropathy (IgAN)

Beyond the preview

Go deeper on NCT00319761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00319761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call